In its "Members Alert" issue for January, 2001 (Vol. 5, No. 7 -- see
copy of front copy at left, or see enlargement),
the monthly publication, Health Sciences Institute Members Alert, published
a front page article entitled, "Billion-dollar drug company nearly
squashes astounding research on natural cancer killer." Since
the botanical plant that is the source of the article, Graviola, is an active
component in our new Cansema Tonic III, we reproduce
excerpts from this article below.
"Two months ago, we learned about
an astounding cancer-fighting tree from the Amazon that has literally
sent shock waves through the HSI network. "Today, the future of cancer treatment
and the chances for survival look more promising than ever. There's a healing
tree that grows deep within the Amazon rain forest in South America that could
literally change how you, your doctor, and possibly the rest of the world think
about curing cancer. With extracts from this powerful tree, it may now be
possible to ... - conquer cancer safely and effectively with an all-natural therapy that doesn't cause extreme nausea, weight loss, and hair loss
- protect your immune system and evade deadly infections
- feel strong and healthy throughout the course of treatment
- boost your energy and improve your outlook on life
"Through a series of confidential
communications involving a researcher from one of America's largest
pharmaceutical companies, this ancient tree's anticancerous properties
have recently come to light. Although not yet tested in human
trials, the tree has been studied in more than 20 laboratory tests since
the 1970's, where it's been shown to: - effectively target and kill malignant cells in 12 different types of cancer, including colon, breast, prostate, lung, and pancreatic cancer
- be 10,000 times stronger in killing colon cancer cells than Adriamycin, a commonly used chemotherapeutic drug
- selectively hunt down and kill cancer cells without harming healthy cells, unlike chemotherapy
"So why isn't every health
publication extolling the benefits of this treatment? Why hasn't
it been made widely available throughout the natural-medicine
community? And, if it's only half as promising as it appears to
be, why isn't every oncologist at every major hospital insisting
on using it on all his patients? Especially when you consider that
since the early 1990's, extensive independent research -- including
research by one of today's leading drug companies and by the
Natural Cancer Institute -- confirms that the tree's chemical
extracts attack and destroy cancer cells with lethal precision.Graviola is 10,000 times stronger in killing colon cancer than Adriamycin, a commonly used chemotherapeutic drug.
"The answer to these difficult
questions can only be explained by recounting a disturbing story we
recently uncovered. More than anything else we've reported on
this year, the story of this Amazon cancer treatment reinforces
the need for groups like HSI and illustrates how easily our options
for medical treatment are controlled by money and power. 
"A confidential source, whose
account we've been able to independently confirm, revealed that a
billion-dollar drug company in the United States tried for nearly
seven years to synthesize two of the tree's most powerful anticancerous
chemicals. In the early 1990's, behind lock and key, this well-known
drug giant began searching for a cure for cancer -- while preciously
guarding their opportunity to patent it and, therefore, profit
from it. "Research focused on a legendary
healing tree called Graviola. Parts of the tree -- including
the bark, leaves, roots, fruit, and fruit seeds -- had been used
for centuries by medicine men and native Indians in South America
to treat heart disease, asthma, liver problems, and arthritis.
Going on little documented scientific evidence, the company poured
money and resources into testing Graviola's anticancerous properties --
and they were shocked with the results. Graviola was a cancer-killing
dynamo. But that's where the story of Graviola nearly ended. "The pharmaceutical company
had a big problem. They'd spent years trying to isolate and
create man-made duplicates of two of the three's most powerful
chemicals. But they'd hit a brick wall. They couldn't replicate
the original. And they couldn't sell the tree extract itself
profitably -- because federal law mandates that natural substances
can't be patented. That meant the company couldn't protect its
profits on the project it had poured millions of dollars and nearly
seven years of research into.testing on Graviola came to a screeching halt
"After seven frustrating
years and without the promise of lucrative sales, the company
shelved the project and refused to publish its findings in
an independent journal. But one responsible researcher
struggled with the decision. While understanding the company's
goal of profits, he couldn't accept the decision to hide
this unique cancer killer from the world. Following his
conscience and risking his career, he contacted
(an Amazonian harvester of botanicals)... "As a result,
(the harvester) went into high gear and began to
research related studies published on Graviola.
They discovered that several other teams in the United
States (in addition to that of the drug company)
had been testing Graviola in vitro (in test tubes).
The results supported the drug company's secret
findings: Graviola had been shown to kill cancer cells...
lung, breast, colon, and pancreatic cancer...
leaving healthy cells alone
"Since November, we've been
looking closely into the research to date on Graviola. It appears
one of the first scientific references to it in the United States
was the National Cancer Institute (NCI). In 1976, the NCI
included Graviola in a plant-screening program that showed
its leaves and stems were effective in attacking and
destroying malignant cells. But the results were part of an
internal NCI report and were, for some reason, never
released to the public (1).
[AO Editor: Sound familiar?] "Since 1976, there have
been several promising cancer studies on Graviola.
However, the tree's extracts have yet to be tested on
cancer patients. No double-blind clinical trials exist,
and clinical trials are typically the benchmark mainstream
doctors and journals use to judge a treatment's value.
Nevertheless, Graviola has been shown to kill cancer
cells in vitro in at least 20 laboratory tests that our
research has uncovered. "The most recent study,
conducted at Catholic University of South Korea earlier this
year, revealed that two chemicals extracted from Graviola
seeds showed "selective cytotoxicity comparable with
Adriamycin" for breast and colon cancer cells. The
chemicals targeted and killed malignant breast and colon
cells in a test tube -- comparable to the commonly
used chemotherapy drug Adriamycin (2)."Another study,
published in the JOurnal of Natural Products,
showed that Graviola is not only comparable to Adriamycin --
but dramatically outperforms it in laboratory tests.
Results showed that one chemical found in Graviola
selectively killed colon cancer cells at
"10,000 times the potency of Adriamycin."
(3). "Other promising
and ongoing research at Purdue University is supported by
a grant from the National Cancer Institute. Purdue
researchers recently found that leaves from the
Graviola tree killed cancer cells "among six human-cell lines"
and were especially effective against prostate and
pancreatic cancer cells. (4).
In a separate study, Purdue researchers showed that
extracts from the Graviola leaves are extremely
effective in isolating and killing lung cancer
cells. (5). "Perhaps the most
significant result of the study cited above from the
Catholic University of South Korea, and of each of the
others we've found, is that Graviola was shown to
selectively target the enemy -- leaving all healthy,
normal cells untouched. [AO Editor: Alpha Omega
customers are accustomed to this phenomenon, as the
entire Cansema product line
exhibits this property.] By comparison, chemotherapy
indiscriminately seeks and destroys all actively
reproducing cells -- even normal hair and stomach
cells. This is what causes such often-devastating
side effects, such as hair loss and severe nausea.
In this respect, Graviola looks to be a promising
alternative or supplement to mainstream
treatments..." AO Editor Comments
This is not the end of the article.HSI goes on to
discuss patient reports using a Graviola product ("N-Tense")
from Raintree Nutrition, which has
its
own extensive web page on Graviola -- a delight for those who want
an in-depth study on this botanical. In addition, HSI covers the
implications of government coverup -- which regular
Alpha Omega customers have known about for years. Our contribution to Graviola
is its inclusion of Cansema Tonic III using a
proprietary process that extracts the active components into aloe,
which is highly bioavailable -- more so than even tonics in which water
or alcohol is the primary substrate. We are in the process of presenting
our own case studies in Graviola, using Cansema Tonic III, which will
be published on this site in the coming weeks to show the efficacy
of our approach as they are completed.Footnotes
1 -- Unpublished data, National Cancer Institute, Anon: Nat Cancer Ist Central Files -- (1978) from Napreiert Files, University of Illinois, 1995.
2 -- Bioorg Med Chem 8(1): 285-90, 2000
3 -- J Nat Prod 59(2):100-108, 1996
4 -- Phytochemistry 49(2):565-71, 1998
5 -- J Nat Prod 58(6):902-908, 1995
Italiano,
Français,
Norsk